270 related articles for article (PubMed ID: 22684366)
1. Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12.
Gelman IH
Cancer Metastasis Rev; 2012 Dec; 31(3-4):493-500. PubMed ID: 22684366
[TBL] [Abstract][Full Text] [Related]
2. Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis.
Gelman IH
Genes Cancer; 2010 Nov; 1(11):1147-56. PubMed ID: 21779438
[TBL] [Abstract][Full Text] [Related]
3. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway.
Su B; Bu Y; Engelberg D; Gelman IH
J Biol Chem; 2010 Feb; 285(7):4578-86. PubMed ID: 20018890
[TBL] [Abstract][Full Text] [Related]
4. Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12.
Guo LW; Gao L; Rothschild J; Su B; Gelman IH
J Biol Chem; 2011 Nov; 286(44):38356-38366. PubMed ID: 21903576
[TBL] [Abstract][Full Text] [Related]
5. Carcinogen-induced squamous papillomas and oncogenic progression in the absence of the SSeCKS/AKAP12 metastasis suppressor correlate with FAK upregulation.
Akakura S; Bouchard R; Bshara W; Morrison C; Gelman IH
Int J Cancer; 2011 Oct; 129(8):2025-31. PubMed ID: 21128249
[TBL] [Abstract][Full Text] [Related]
6. Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12.
Akakura S; Nochajski P; Gao L; Sotomayor P; Matsui S; Gelman IH
Cell Cycle; 2010 Dec; 9(23):4656-65. PubMed ID: 21099353
[TBL] [Abstract][Full Text] [Related]
7. Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12.
Su B; Gao L; Meng F; Guo LW; Rothschild J; Gelman IH
Oncogene; 2013 Apr; 32(16):2016-26. PubMed ID: 22710722
[TBL] [Abstract][Full Text] [Related]
8. Pivotal Role of AKAP12 in the Regulation of Cellular Adhesion Dynamics: Control of Cytoskeletal Architecture, Cell Migration, and Mitogenic Signaling.
Akakura S; Gelman IH
J Signal Transduct; 2012; 2012():529179. PubMed ID: 22811901
[TBL] [Abstract][Full Text] [Related]
9. The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development .
Gelman IH
Front Biosci; 2002 Aug; 7():d1782-97. PubMed ID: 12133808
[TBL] [Abstract][Full Text] [Related]
10. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
Xia W; Unger P; Miller L; Nelson J; Gelman IH
Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
[TBL] [Abstract][Full Text] [Related]
11. SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition.
Su B; Zheng Q; Vaughan MM; Bu Y; Gelman IH
Cancer Res; 2006 Jun; 66(11):5599-607. PubMed ID: 16740695
[TBL] [Abstract][Full Text] [Related]
12. SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis.
Liu Y; Gao L; Gelman IH
BMC Cancer; 2006 Apr; 6():105. PubMed ID: 16638134
[TBL] [Abstract][Full Text] [Related]
13. A-kinase anchor protein 12 (AKAP12) inhibits cell migration in breast cancer.
Soh RYZ; Lim JP; Samy RP; Chua PJ; Bay BH
Exp Mol Pathol; 2018 Dec; 105(3):364-370. PubMed ID: 30385176
[TBL] [Abstract][Full Text] [Related]
14. SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways.
Gelman IH; Gao L
Mol Cancer Res; 2006 Mar; 4(3):151-8. PubMed ID: 16547152
[TBL] [Abstract][Full Text] [Related]
15. SSeCKS/AKAP12 scaffolding functions suppress B16F10-induced peritoneal metastasis by attenuating CXCL9/10 secretion by resident fibroblasts.
Muramatsu M; Gao L; Peresie J; Balderman B; Akakura S; Gelman IH
Oncotarget; 2017 Sep; 8(41):70281-70298. PubMed ID: 29050279
[TBL] [Abstract][Full Text] [Related]
16. Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia.
Akakura S; Huang C; Nelson PJ; Foster B; Gelman IH
Cancer Res; 2008 Jul; 68(13):5096-103. PubMed ID: 18593908
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic induction of AKAP12 variant 2 shifts PKA-mediated protein phosphorylation to enhance migration and metastasis of melanoma cells.
Finger EC; Castellini L; Rankin EB; Vilalta M; Krieg AJ; Jiang D; Banh A; Zundel W; Powell MB; Giaccia AJ
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4441-6. PubMed ID: 25792458
[TBL] [Abstract][Full Text] [Related]
18. Re-expression of AKAP12 inhibits progression and metastasis potential of colorectal carcinoma in vivo and in vitro.
Liu W; Guan M; Hu T; Gu X; Lu Y
PLoS One; 2011; 6(8):e24015. PubMed ID: 21918680
[TBL] [Abstract][Full Text] [Related]
19. Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS.
Lin X; Gelman IH
Biochem Biophys Res Commun; 2002 Feb; 290(5):1368-75. PubMed ID: 11820772
[TBL] [Abstract][Full Text] [Related]
20. SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk.
Muramatsu M; Akakura S; Gao L; Peresie J; Balderman B; Gelman IH
Oncotarget; 2018 Sep; 9(71):33515-33527. PubMed ID: 30323895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
